—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Globus Medical (GMED) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for GMED, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index HALO Growth 100 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-09-25

DayWeekMonth3 months
GMED+0.3%+0.6%−10.3%−13.6%
Surgical, Med Devices & Animal Health+0.2%+1.4%−3.7%—
HALO Growth 1000.0%+0.2%−7.6%—

Against the index: 0.4 pts ahead on the week, 2.7 pts behind on the month; against its Surgical, Med Devices & Animal Health sleeve 6.6 pts behind on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sector × region Health care in US: +1.8% week · −1.3% month · +6.9% quarter · +13.1% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-27
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.64 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How GMED has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.64 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Globus Medical moved 0.64% on average · correlation 0.12 · higher than 65% of US names
  • Beta, last 3 months 0.68 about the same as over the year
  • On the 10 worst bond days −0.94% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +0.42% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against HALO Growth 100 · Surgical, Med Devices & Animal Health · 7 names with week and year-to-date

Peer group

HALO Growth 100 · Surgical, Med Devices & Animal Health

Robotic surgery, continuous-glucose sensors, cochlear implants, animal-health platforms. Regulated moats, multi-decade compounders.

Compared against GMED on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Globus Medical

GMED in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Globus Medical makes implants and instruments for spine, orthopaedic trauma and hip-and-knee surgery, treating musculoskeletal disorders. It also builds the ExcelsiusGPS robotic guidance platform and related navigation and neuromonitoring tools used during procedures. The company is based in Audubon, United States, and sells through direct and distributor channels in the US and abroad.
Where it sits in the stack
Globus Medical carries no seat in Rubin or Halo, our AI-stack indices; it sits instead in the HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve, a group of regulated device and diagnostics compounders.
Who it is priced against
Closelooknet's peer group places it with regulated medical-device and animal-health names — IDEXX Laboratories, Intuitive Surgical, Sonova, Stryker, Sartorius, DexCom and Insulet — grouped for their multi-decade regulatory moats; the market also compares it with Medtronic.
Why Closelooknet tracks it
Globus Medical is a HALO Growth 100 constituent and carries a Closelooknet score across seven modules, where valuation reads strongest and momentum weakest; the diary has not yet quoted it directly.
What the diary watches
Whether the stock's slide below its 50-day and 200-day levels and its weak place on the Directional Flow list steadies, or whether adoption of the Excelsius robotic platforms lifts the read.

Globus Medical (GMED) trades on US exchanges, classified under Healthcare. Constituent of HALO Growth 100.

The Closelooknet company score reads 59/100 composite (momentum 21, quality 64, valuation 59) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return no distribution in twelve months · buybacks 300 m USD in FY2025

Dividends and capital return

What GMED pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Buybacks, FY2025 300 m USD 3.0% of today's market value
  • Share count −0.5% in FY2025 50 m USD of stock-based compensation in the year
  • Capital returned 300 m USD · 51% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Globus Medical (GMED)?

Globus Medical trades as GMED on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is GMED in a Closelooknet index?

Yes — Globus Medical is a constituent of HALO Growth 100, as of 2026-09-26.

What is Globus Medical's Closelooknet composite score?

59 out of 100, with momentum 21, quality 64 and valuation 59 sub-scores, as of 2026-09-26. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does GMED trade against its moving averages?

Stochastic turned up: Its stochastic crossed up out of oversold (%K 20.6 over %D 18.3) 3 sessions ago — a short-term momentum-turn signal. As of 2026-09-24 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is GMED doing against its Closelooknet index?

Over the past month Globus Medical is −10.3% against −7.6% for the HALO Growth 100 — 2.7 points behind its index, as of 2026-09-25. Its Surgical, Med Devices & Animal Health sleeve is −3.7% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

How does Globus Medical trade when bond yields rise?

Over the past year Globus Medical had a beta of 0.64 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 65% of US names. On the 10 sessions in which long bonds fell most it moved −0.94% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Globus Medical do?

Globus Medical makes implants and instruments for spine, orthopaedic trauma and hip-and-knee surgery, treating musculoskeletal disorders. It also builds the ExcelsiusGPS robotic guidance platform and related navigation and neuromonitoring tools used during procedures. The company is based in Audubon, United States, and sells through direct and distributor channels in the US and abroad. Closelooknet's peer group places it with regulated medical-device and animal-health names — IDEXX Laboratories, Intuitive Surgical, Sonova, Stryker, Sartorius, DexCom and Insulet — grouped for their multi-decade regulatory moats; the market also compares it with Medtronic.

Where does Globus Medical sit in the AI build-out?

Globus Medical carries no seat in Rubin or Halo, our AI-stack indices; it sits instead in the HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve, a group of regulated device and diagnostics compounders. Globus Medical is a HALO Growth 100 constituent and carries a Closelooknet score across seven modules, where valuation reads strongest and momentum weakest; the diary has not yet quoted it directly.

Does Globus Medical pay a dividend?

No cash distribution shows in Globus Medical’s price series over the last three years. In fiscal 2025 the company bought back 300 m USD of its own shares, 51% of that year’s free cash flow. The share count fell 0.5% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for GMED, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.